Current NDC auxiliary source row compounder:50
This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.
Complete normalized row#
- Record Source
- ndc_compounder_zip
- Product Ndc Raw
- 71285-0212
- Product Ndc
- 71285-0212
- Product Ndc Digits
- 712850212
- Product Type Name
- HUMAN COMPOUNDED DRUG
- Proprietary Name
- Induction 4 to1 High K (30 meq) In PL A
- Proprietary Name Suffix
- Nonproprietary Name
- Induction 4 to1 High K (30 meq) In PL A
- Dosage Form Name
- SOLUTION
- Route Name
- INTRACORONARY
- Marketing Category Name
- OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
- Labeler Name
- Central Admixture Pharmacy Services, Inc.
- Establishment Name
- Central Admixture Pharmacy Services, Inc.
- Establishment Fei
- Substance Name
- SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE
- Active Ingredients Info
- 2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL
- History Active Ingredients Raw
- SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE
- History Active Ingredients Info Raw
- 2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL
- History Dosage Raw
- SOLUTION
- Dea Schedule
- Package Ndc Raw
- 71285-0212-1
- Package Ndc
- 71285-0212-1
- Package Ndc Digits
- 7128502121
- Package Ndc11
- 71285021201
- Package Description
- 542 mL in 1 BAG (71285-0212-1)
- Reporting Period Raw
- 2026-1
- Reporting Period
- 2026-1
- Normalization Status
- valid
- Source Archive
- compounders_ndc_directory.zip
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Last Modified
- Fri, 18 Sep 2026 15:17:23 GMT
- Source Archive Sha256
- 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
- Source Member Sha256
- f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
- Source Record Id
- compounder:50
- Source Row Number
- 50
- Source Row Hash
- 592ba88b15b97a8ae79f27695c3882206b1002162042c54b9440419e5ab3070a
- Import Run Id
- 20261018T022251Z
- Loaded At
- 2026-10-18 02:29:51
Exact raw FDA source fields#
{
"ROUTENAME": "INTRACORONARY",
"PRODUCTNDC": "71285-0212",
"DEASCHEDULE": "",
"LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
"SUBSTANCENAME": "SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE",
"DOSAGEFORMNAME": "SOLUTION",
"NDCPACKAGECODE": "71285-0212-1",
"PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
"PROPRIETARYNAME": "Induction 4 to1 High K (30 meq) In PL A",
"REPORTINGPERIOD": "2026-1",
"NONPROPRIETARYNAME": "Induction 4 to1 High K (30 meq) In PL A",
"PACKAGEDESCRIPTION": "542 mL in 1 BAG (71285-0212-1) ",
"ACTIVEINGREDIENTSINFO": "2.63 g/542 mL; 2.51 g/542 mL; 1.84 g/542 mL; 2.42 g/542 mL; .15 g/542 mL; 100 mg/542 mL; 1.848 g/542 mL",
"MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
"PROPRIETARYNAMESUFFIX": ""
}Normalization notes#
[]Current status projection#
- Dataset
- compounder
- Record Source
- ndc_compounder_zip
- Source Record Id
- compounder:50
- Source Row Number
- 50
- Status Scope
- package
- Lookup Ndc
- 71285-0212-1
- Lookup Ndc Digits
- 7128502121
- Product Ndc
- 71285-0212
- Product Ndc Digits
- 712850212
- Package Ndc
- 71285-0212-1
- Package Ndc Digits
- 7128502121
- Package Ndc11
- 71285021201
- Product Id
- Status Code
- COMPOUNDER
- Status Label
- Outsourcing facility compounded drug report
- Reporting Period Raw
- 2026-1
- Reporting Period
- 2026-1
- Source Table
- fda_ndc_aux_compounder
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Row Hash
- 592ba88b15b97a8ae79f27695c3882206b1002162042c54b9440419e5ab3070a
- Import Run Id
- 20261018T022251Z
- Loaded At
- 2026-10-18 02:29:51